Company Filing History:
2 out of 4 
2 out of 12 
2 out of 3 Years Active: 2001-2018
Title: The Innovative Contributions of Henrich Cheng
Introduction
Henrich Cheng is a notable inventor based in Taipei, Taiwan, recognized for his impactful contributions to the field of biomedical innovations. With a remarkable portfolio of 12 patents, Cheng has demonstrated a commitment to advancing healthcare technologies, particularly in the area of neuroprotection and spinal cord injury treatment.
Latest Patents
Among his most recent patents, Cheng has developed a recombinant decoy receptor 3 for treating spinal cord injuries. This innovative method involves the use of the recombinant decoy receptor 3 (DcR3) polypeptide, significantly enhancing recovery in locomotor function for spinal cord-injured subjects. Additionally, he has patented a method for repairing neurodegeneration, targeting conditions caused by nerve compression syndrome or entrapment neuropathy. This invention utilizes a unique combination of human acidic fibroblast growth factor (aFGF), fibrinogen, aprotinin, and divalent calcium ions to promote effective treatment for affected subjects.
Career Highlights
Cheng's career is marked by key contributions to various biotech firms. Notably, he has had significant engagements with Eu Sol Biotech Co., Ltd., where his expertise in biomedical sciences was instrumental in pioneering innovative solutions for nerve-related disorders. His work continues to pave the way for new therapeutic interventions.
Collaborations
Throughout his career, Cheng has collaborated with prominent figures in the field. Notable coworkers include Lars Olson and Wen-Chun Kuo, both of whom have contributed to advancing the research and development efforts surrounding Cheng's patented technologies.
Conclusion
Henrich Cheng's contributions to the world of medical innovation highlight his dedication to improving patient outcomes through advanced therapies. His patents not only showcase his ingenuity as an inventor but also represent significant advancements in treating spinal cord injuries and neurodegenerative conditions. As research continues, Cheng's work is likely to inspire further innovations in the biomedical arena.